Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:193616rdf:typepubmed:Citationlld:pubmed
pubmed-article:193616lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0026972lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0004372lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:193616lifeskim:mentionsumls-concept:C0444498lld:lifeskim
pubmed-article:193616pubmed:issue1lld:pubmed
pubmed-article:193616pubmed:dateCreated1977-7-18lld:pubmed
pubmed-article:193616pubmed:abstractTextThe effects of postmortem autolysis in situ on myelin proteins and glycoproteins were studied in 25- and 125-day-old mouse brain and in adult bovine brainstem. In bovine myelin a loss of the major myelin glycoprotein was the only difference observed when the tissue was left at 19 degrees C for 24 hours compared to immediately frozen material. In the autolysed mouse brain, the myelin major glycoprotein was the most affected component with a 55% decrease. Both myelin basic protein components were degraded with a 35% loss. The other myelin proteins did not change under the conditions used for this study. There was also no change in the specific activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase, a myelin-associated enzyme. Using the double labelling technique with [3H]fucose and [3 5S] sulfate as precursors injected intracranially, a shift of the major myelin glycoprotein labelled with radioactive sulfate towards a smaller apparent molecular size was observed as a result of the autolysis whereas the electrophoretic mobility of the fucose labelled major peak was unaffected.lld:pubmed
pubmed-article:193616pubmed:languageenglld:pubmed
pubmed-article:193616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:193616pubmed:citationSubsetIMlld:pubmed
pubmed-article:193616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:193616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:193616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:193616pubmed:statusMEDLINElld:pubmed
pubmed-article:193616pubmed:issn0361-9230lld:pubmed
pubmed-article:193616pubmed:authorpubmed-author:MatthieuJ MJMlld:pubmed
pubmed-article:193616pubmed:authorpubmed-author:JoyetM LMLlld:pubmed
pubmed-article:193616pubmed:authorpubmed-author:KoellreutterB...lld:pubmed
pubmed-article:193616pubmed:issnTypePrintlld:pubmed
pubmed-article:193616pubmed:volume2lld:pubmed
pubmed-article:193616pubmed:ownerNLMlld:pubmed
pubmed-article:193616pubmed:authorsCompleteYlld:pubmed
pubmed-article:193616pubmed:pagination15-21lld:pubmed
pubmed-article:193616pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-A...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-A...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-M...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-B...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-C...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-G...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-B...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-A...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-M...lld:pubmed
pubmed-article:193616pubmed:meshHeadingpubmed-meshheading:193616-2...lld:pubmed
pubmed-article:193616pubmed:articleTitleChanges in CNS myelin proteins and glycoproteins after in situ autolysis.lld:pubmed
pubmed-article:193616pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:193616lld:pubmed